Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

Published:2017-05 Issue:5 Volume:25 Page:1054-1062.e5
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Loomba Rohit,Seguritan Victor,Li Weizhong,Long Tao,Klitgord Niels,Bhatt Archana,Dulai Parambir Singh,Caussy Cyrielle,Bettencourt Richele,Highlander Sarah K.,Jones Marcus B.,Sirlin Claude B.,Schnabl Bernd,Brinkac Lauren,Schork Nicholas,Chen Chi-Hua,Brenner David A.,Biggs William,Yooseph Shibu,Venter J. Craig,Nelson Karen E.

Funder

National Institute of Environmental Health Sciences

John A. Hartford Foundation

National Institutes of Health

Atlantic Philanthropies

University of California, San Diego

American Gastroenterological Association

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference46 articles.

1. The natural history of nonalcoholic fatty liver disease: a population-based cohort study;Adams;Gastroenterology,2005

2. CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis;Affò;Gut,2014

3. Targeting dysbiosis for the treatment of liver disease;Anand;Semin. Liver Dis.,2016

4. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease;Angulo;Gastroenterology,2015

5. Inhibition of the translocation and extracellular release of high-mobility group box 1 alleviates liver damage in fibrotic mice in response to D-galactosamine/lipopolysaccharide challenge;Bai;Mol. Med. Rep.,2016

Cited by 780 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies;Metabolism;2024-12

2. Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine;The Journal of Nutritional Biochemistry;2024-11

3. The role of lycopene in alleviating nanoplastic-induced liver inflammation and steatosis: Insights from gut microbiota remodeling;Food Bioscience;2024-10

4. Artemisia argyi ethanol extract ameliorates nonalcoholic steatohepatitis-induced liver fibrosis by modulating gut microbiota and hepatic signaling;Journal of Ethnopharmacology;2024-10

5. Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn’s disease;EMBO Molecular Medicine;2024-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3